|
× |
 |
COVID-19 and Obsessive-Compulsive Disorder: The Nightmare Just Got Real PDF |
$40.00 |
|
$40.00 |
|
× |
|
Electroconvulsive Therapy Device Classification: Response to FDA Advisory Panel Hearing and Recommendations PDF |
$40.00 |
|
$40.00 |
|
× |
|
Suicidal Behavior in Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 1 PDF |
$40.00 |
|
$40.00 |
|
|
